Concord Healthcare Grp (2453) Fundamentals 2026 — Revenue Analysis | SniperIQ
Concord Healthcare Grp (2453) is a CN-listed Healthcare company in Medical - Care Facilities with a market capitalization of HK$572M, trading at HK$0.73 on the HKSE. This SniperIQ fundamentals page covers Concord Healthcare Grp's valuation, profitability (net margin -57.0%), revenue (¥448M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Concord Healthcare Grp's market cap?
Concord Healthcare Grp (2453) has a market capitalization of approximately HK$572M, trading at HK$0.73 on the HKSE. Market cap moves with the live share price.
What is Concord Healthcare Grp's P/E ratio?
Concord Healthcare Grp's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Concord Healthcare Grp?
Concord Healthcare Grp runs a net profit margin of -57.0%, a gross margin of 6.9%, and an operating margin of -46.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Concord Healthcare Grp generate?
Concord Healthcare Grp reported revenue of ¥448M for fiscal year 2025, with net income of -¥250M and earnings per share (EPS) of -0.33. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Concord Healthcare Grp pay a dividend?
Concord Healthcare Grp does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Concord Healthcare Grp financially healthy?
Concord Healthcare Grp carries a debt-to-equity ratio of 1.69x and a current ratio of 0.54x, with a market beta of -0.58. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Concord Healthcare Grp a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Concord Healthcare Grp (2453) the key facts are: market cap HK$572M, revenue ¥448M, 52-week range 0.65-6.58. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Concord Healthcare Grp's full fundamentals live
Get Concord Healthcare Grp's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.